Yerson Alberca-Naira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yerson Alberca-Naira has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Bryam López
Departamento de Cardiología, Hospital Nacional Edgardo Rebagliati, Lima 15072, Peru
2 shared publications - Joshuan Barboza Meca
Vicerrectorado de Investigación, Universidad Señor de Sipán, Chiclayo 14001, Peru
2 shared publications - Abdias Baltazar Castellanos
Escuela de Enfermeria, Universidad Autónoma del Estado de México, Valle de Chalco 56615, Mexico
1 shared publication - Abdul Mohsin Ashraf Mohammad
Zambia Field Epidemiology Training Program, Lusaka, Zambia
1 shared publication - Achref Jebnouni
Medical Surgical Nursing Department, College of Nursing, University of Hail, Hail, Kingdom of Saudi Arabia
1 shared publication - Aesha L. E. Enairat
Faculty of Graduate Studies, Medical Imaging Technology, Al-Quds University, Palestine
1 shared publication
Latest Publications
- Open Access
- 5 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5255
Prediction Models for Postoperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Critical Appraisal
Background/Objectives: Postoperative atrial fibrillation (POAF) is a frequent complication after cardiac surgery and is associated with increased morbidity, prolonged hospitalization, and higher healthcare costs. Numerous multivariable prediction models have been developed to estimate individual risk; however, their methodological robustness, validation status, and clinical transportability remain uncertain. This systematic review aimed to critically evaluate the methodological quality, validation strategies, and predictive performance of multivariable prediction models developed to estimate the risk of postoperative atrial fibrillation (POAF) after cardiac surgery. Methods: In accordance with PRISMA 2020 guidelines, we conducted a comprehensive search of PubMed, Scopus, Web of Science, and Embase from inception to July 2025. Studies that developed or externally validated multivariable prediction models for POAF in adult patients undergoing cardiac surgery were eligible. Data extraction was performed using the CHARMS checklist, and methodological quality was assessed with PROBAST. Model performance was summarized descriptively, focusing on discrimination (C-statistic/AUC), calibration reporting, and validation strategies. Results: A total of 39 studies were included. Most models were based on logistic regression, whereas a minority employed Cox regression or machine learning techniques. Reported discrimination ranged from 0.60 to 0.98, demonstrating substantial heterogeneity in predictive performance. Calibration was inconsistently reported. Six studies performed external validation. According to PROBAST, 32 of 39 studies (82%) were rated at high risk of bias, predominantly within the analysis domain due to inadequate handling of overfitting, insufficient events-per-variable ratios, and limited validation procedures. Conclusions: Existing prediction models for POAF show variable discrimination but are frequently limited by high risk of bias, inadequate validation, and incomplete calibration assessment, thereby restricting their clinical applicability. Future research should prioritize rigorous external validation, transparent reporting in accordance with TRIPOD recommendations, and methodological strategies that enhance model generalizability and transportability across diverse surgical populations.
- 5 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5255
Open AccessPrediction Models for Postoperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Critical Appraisal
Background/Objectives: Postoperative atrial fibrillation (POAF) is a frequent complication after cardiac surgery and is associated with increased morbidity, prolonged hospitalization, and higher healthcare costs. Numerous multivariable prediction models have been developed to estimate individual risk; however, their methodological robustness, validation status, and clinical transportability remain uncertain. This systematic review aimed to critically evaluate the methodological quality, validation strategies, and predictive performance of multivariable prediction models developed to estimate the risk of postoperative atrial fibrillation (POAF) after cardiac surgery. Methods: In accordance with PRISMA 2020 guidelines, we conducted a comprehensive search of PubMed, Scopus, Web of Science, and Embase from inception to July 2025. Studies that developed or externally validated multivariable prediction models for POAF in adult patients undergoing cardiac surgery were eligible. Data extraction was performed using the CHARMS checklist, and methodological quality was assessed with PROBAST. Model performance was summarized descriptively, focusing on discrimination (C-statistic/AUC), calibration reporting, and validation strategies. Results: A total of 39 studies were included. Most models were based on logistic regression, whereas a minority employed Cox regression or machine learning techniques. Reported discrimination ranged from 0.60 to 0.98, demonstrating substantial heterogeneity in predictive performance. Calibration was inconsistently reported. Six studies performed external validation. According to PROBAST, 32 of 39 studies (82%) were rated at high risk of bias, predominantly within the analysis domain due to inadequate handling of overfitting, insufficient events-per-variable ratios, and limited validation procedures. Conclusions: Existing prediction models for POAF show variable discrimination but are frequently limited by high risk of bias, inadequate validation, and incomplete calibration assessment, thereby restricting their clinical applicability. Future research should prioritize rigorous external validation, transparent reporting in accordance with TRIPOD recommendations, and methodological strategies that enhance model generalizability and transportability across diverse surgical populations.
- 28 November 2025
- Published by Springer Nature in Medical Science Educator
- Vol. 35 (6) , 3185-3206
Implementation of the Comprehensive Basic Science Examination in Medicine: A Scoping Review of the Global Level
Background The Comprehensive Basic Science Examination (CBSE) is a widely used tool in undergraduate medical education to assess foundational knowledge in basic sciences and predict future academic performance. Despite its increasing international adoption, the extent and nature of its implementation across diverse educational contexts remain unclear. Objective This scoping review aims to synthesize the available evidence on the global implementation of the CBSE, focusing on its characteristics, assessment approaches, reported outcomes, and limitations. Methods Following the Joanna Briggs Institute (JBI) methodology and PRISMA-ScR guidelines, five databases and gray literature sources were searched. Sixteen peer-reviewed studies conducted in six countries were included. The methodological quality of the studies was evaluated using the Medical Education Research Study Quality Instrument (MERSQI). Results The CBSE was used primarily in Iran, the United States, and South Korea, either as the standardized NBME version or as institution-specific adaptations. Most implementations were summative in nature, though formative and diagnostic approaches were also reported. The CBSE showed positive correlations with academic performance indicators such as GPA and licensing exam scores (e.g., USMLE Step 1, CPIE). However, limitations included resource constraints, variability in predictive validity, lack of alignment with curricula, and heterogeneous exam structures. The average methodological quality of the included studies was moderate. Conclusions The CBSE is a promising assessment tool for evaluating medical students’ basic science knowledge and predicting academic outcomes. However, its use and effectiveness vary significantly across contexts. To optimize its implementation, institutions should consider curricular alignment, resource availability, and local validation. Further high-quality, multicenter research is needed to enhance its applicability and reliability in global medical education.
- 28 November 2025
- Published by Springer Nature in Medical Science Educator
- Vol. 35 (6) , 3185-3206
Implementation of the Comprehensive Basic Science Examination in Medicine: A Scoping Review of the Global Level
Background The Comprehensive Basic Science Examination (CBSE) is a widely used tool in undergraduate medical education to assess foundational knowledge in basic sciences and predict future academic performance. Despite its increasing international adoption, the extent and nature of its implementation across diverse educational contexts remain unclear. Objective This scoping review aims to synthesize the available evidence on the global implementation of the CBSE, focusing on its characteristics, assessment approaches, reported outcomes, and limitations. Methods Following the Joanna Briggs Institute (JBI) methodology and PRISMA-ScR guidelines, five databases and gray literature sources were searched. Sixteen peer-reviewed studies conducted in six countries were included. The methodological quality of the studies was evaluated using the Medical Education Research Study Quality Instrument (MERSQI). Results The CBSE was used primarily in Iran, the United States, and South Korea, either as the standardized NBME version or as institution-specific adaptations. Most implementations were summative in nature, though formative and diagnostic approaches were also reported. The CBSE showed positive correlations with academic performance indicators such as GPA and licensing exam scores (e.g., USMLE Step 1, CPIE). However, limitations included resource constraints, variability in predictive validity, lack of alignment with curricula, and heterogeneous exam structures. The average methodological quality of the included studies was moderate. Conclusions The CBSE is a promising assessment tool for evaluating medical students’ basic science knowledge and predicting academic outcomes. However, its use and effectiveness vary significantly across contexts. To optimize its implementation, institutions should consider curricular alignment, resource availability, and local validation. Further high-quality, multicenter research is needed to enhance its applicability and reliability in global medical education.
- 8 November 2025
- Published by Elsevier in Public Health
- Vol. 249, 106037
Internet addiction among youth across 26 countries: psychological, personality, and socioeconomic determinants
- 8 November 2025
- Published by Elsevier in Public Health
- Vol. 249, 106037
Internet addiction among youth across 26 countries: psychological, personality, and socioeconomic determinants
- Open Access
- 21 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2157
Ozenoxacin 1% in Pediatric and Adult Patients with Impetigo: A Meta-Analysis of Randomized Trials
Introduction: Impetigo is a relatively common superficial infection of the skin and soft tissues. Although its prevalence is more significant in childhood, it might also occur in adulthood, affecting the quality of life of our patients. Methods: A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing ozenoxacin 1% with placebo or mupirocin was conducted. Databases searched included PubMed, Embase, Cochrane Library, and ClinicalTrials.gov. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were estimated using a random-effects model, and heterogeneity was assessed using I2 statistics. Results: Four RCTs with 754 patients met the inclusion criteria. Ozenoxacin significantly improved the clinical success (RR: 1.14, 95% CI: 1.04–1.26, and I2 = 0%) and reduced the clinical failure (RR: 0.54, 95% CI: 0.39–0.75, and I2 = 0%) compared to the placebo. Microbiological success was also superior (RR: 1.31, 95% CI: 1.05–1.58, and I2 = 4%), while the microbiological failure was significantly lower (RR: 0.31, 95% CI: 0.21–0.46, and I2 = 0%). Comparisons with mupirocin showed similar efficacy, though the estimates were less precise. Conclusions: Ozenoxacin 1% is an effective treatment for impetigo, significantly improving clinical and microbiological outcomes while reducing the failure rates compared to the placebo. Its efficacy is comparable to mupirocin, suggesting it as a viable alternative for first-line therapy. Given the low heterogeneity observed, these findings support the clinical use of ozenoxacin for impetigo management. Future large-scale RCTs and direct comparative studies are warranted to further validate its therapeutic benefits.
- 21 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2157
Open AccessOzenoxacin 1% in Pediatric and Adult Patients with Impetigo: A Meta-Analysis of Randomized Trials
Introduction: Impetigo is a relatively common superficial infection of the skin and soft tissues. Although its prevalence is more significant in childhood, it might also occur in adulthood, affecting the quality of life of our patients. Methods: A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing ozenoxacin 1% with placebo or mupirocin was conducted. Databases searched included PubMed, Embase, Cochrane Library, and ClinicalTrials.gov. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were estimated using a random-effects model, and heterogeneity was assessed using I2 statistics. Results: Four RCTs with 754 patients met the inclusion criteria. Ozenoxacin significantly improved the clinical success (RR: 1.14, 95% CI: 1.04–1.26, and I2 = 0%) and reduced the clinical failure (RR: 0.54, 95% CI: 0.39–0.75, and I2 = 0%) compared to the placebo. Microbiological success was also superior (RR: 1.31, 95% CI: 1.05–1.58, and I2 = 4%), while the microbiological failure was significantly lower (RR: 0.31, 95% CI: 0.21–0.46, and I2 = 0%). Comparisons with mupirocin showed similar efficacy, though the estimates were less precise. Conclusions: Ozenoxacin 1% is an effective treatment for impetigo, significantly improving clinical and microbiological outcomes while reducing the failure rates compared to the placebo. Its efficacy is comparable to mupirocin, suggesting it as a viable alternative for first-line therapy. Given the low heterogeneity observed, these findings support the clinical use of ozenoxacin for impetigo management. Future large-scale RCTs and direct comparative studies are warranted to further validate its therapeutic benefits.